You are here: Industry Insights > Diabetes

News List

UK team develops novel skin patch for diabetes biospectrumasia
April 16, 2018
The patch does not pierce the skin, instead it draws glucose out from fluid between cells across hair follicles.
Adhesive patch offers bloodless diabetes monitoring europeanpharmaceuticalreview
April 13, 2018
Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test…
ARKAY Therapeutics Submits Investigational New Drug (IND) Application for RK-01, a First-in Class ‘Beta-cell-centric’ Drug Combination Product for Type 2 Diabetes biospace
April 12, 2018
First Human Proof-of-Concept (PoC) Trial to Test the Superiority of RK-01 over Metformin in Type 2 Diabetes Patients with Inadequate Glycemic Control.
ReShape Lifesciences Pioneers New Bio-electronic Technology for Treatment of Type 2 Diabetes biospace
April 11, 2018
ReShape Lifesciences Inc. announced today that the Company will be presenting early results of a new, novel use of the ReShape Lifesciences™ neuro-blocking technology in combination with separate-site vagus nerve stimulation for the treatment of type 2
Lilly and Sigilon to collaborate on cell encapsulation for diabetes pharmaceutical-technolog
April 09, 2018
Eli Lilly and Sigilon Therapeutics have announced a strategic collaboration to develop encapsulated cell therapies for type 1 diabetes.
Eating Pecans May Cut Risk of Cardiovascular Disease, Diabetes drugs
April 09, 2018
Eating pecans every day for four weeks improves certain markers of cardiometabolic disease risk, according to a study published online March 11 in Nutrients.
EMA to review Sanofi’s type I diabetes therapy pharmatimes
March 30, 2018
The European Medicines Agency has accepted for review Sanofi's experimental type I diabetes therapy sotagliflozi.
Real world data back Sanofi’s Toujeo for type I diabetes pharmatimes
March 21, 2018
Sanofi has unveiled real-world data from the UK showing the efficacy of its long-acting basal insulin analogue Toujeo in treating patients with type I diabetes.
AstraZeneca Presents New Data Evaluating Safety and Efficacy of FARXIGA in Patients with Type 2 Diab biospace AstraZeneca today announced the results o
March 20, 2018
AstraZeneca today announced the results of DERIVE, a Phase 3 study that evaluated the efficacy and safety of FARXIGA®(dapagliflozin 10 mg), in patients with type 2 diabetes (T2D) with moderate renal impairment
Patients on diabetes scheme shed weight of 15 double cheeseburgers pharmatimes
March 16, 2018
According to NHS England more than half of patients routinely attending sessions offered as part of its diabetes prevention programme have achieved weight losss equivalent to nearly 15 double cheeseburgers.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page